[Comparative pharmacokinetics of fosfomycin in the neonate: 2 modes of administration].
In newborn, fosfomycin-cefotaxime in combination is more and more commonly used for the treatment of nosocomial infections. A pharmacokinetic study was conducted in ten newborns in the aim of suggesting a therapeutic schedule of the fosfomycin. Each newborn received 200 mg/kg, intravenously twice a day. Two groups have been formed according to the time of perfusion: 2 h or 30 min. The study of pharmacokinetic parameters do not demonstrated significant difference between the two populations. In addition, residual serum concentrations, twelve hours after the administration, are greater than the minimal inhibitory concentrations of most common pathogens causing nosocomial infections in neonates.
Guibert
M
M
Laboratoire de Bactériologie, Hôpital Antoine-Béclère, Clamart.
Magny
J F
JF
Poudenx
F
F
Lebrun
L
L
Dehan
M
M
D000367:Age Factors; D001424:Bacterial Infections / Q000188:drug therapy; D003428:Cross Infection / Q000188:drug therapy; D005578:Fosfomycin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007275:Injections, Intravenous
D005578:Fosfomycin
Pharmacocinétique comparée de la fosfomycine au cours de deux modalités d'administration chez le nouveau-né.